Cargando…
Renal Tubular Acidosis an Adverse Effect of PD-1 Inhibitor Immunotherapy
Immune checkpoint blockade therapy is gaining popularity among oncologists for treatment of solid and hematologic malignancies. The widespread use of these agents resulted in increasing incidence of renal immune-related adverse events. Reported renal toxicity described so far includes acute intersti...
Autores principales: | El Bitar, Sandy, Weerasinghe, Chanudi, El-Charabaty, Elie, Odaimi, Marcel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5831873/ https://www.ncbi.nlm.nih.gov/pubmed/29666732 http://dx.doi.org/10.1155/2018/8408015 |
Ejemplares similares
-
An Overlapping Case of Lupus Nephritis and IgG4-Related Kidney Disease
por: Zaarour, Mazen, et al.
Publicado: (2015) -
Renal Tubular Acidosis and Immune Checkpoint Inhibitor Therapy: An Immune-Related Adverse Event of PD-1 Inhibitor—A Report of 3 Cases
por: Herrmann, Sandra M., et al.
Publicado: (2020) -
Type 3 renal tubular acidosis
por: Goswami, R. P., et al.
Publicado: (2012) -
What we know about surgical therapy in early-stage non-small-cell lung cancer: a guide for the medical oncologist
por: Ghanem, Sassine, et al.
Publicado: (2017) -
Renal Tubular Acidosis in Patients with Primary Sjögren's Syndrome
por: Jung, Su Woong, et al.
Publicado: (2017)